Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies

BACKGROUND: Most of the results regarding hydrogen (H(2)) therapy for acute cerebral ischemia are derived from in vitro studies and animal experiments, with only a few obtained from human trials with a limited number of subjects. Thus, there is a paucity of information regarding both the beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagatani, Kimihiro, Nawashiro, Hiroshi, Takeuchi, Satoru, Tomura, Satoshi, Otani, Naoki, Osada, Hideo, Wada, Kojiro, Katoh, Hiroshi, Tsuzuki, Nobusuke, Mori, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694409/
https://www.ncbi.nlm.nih.gov/pubmed/23799921
http://dx.doi.org/10.1186/2045-9912-3-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694409/
https://www.ncbi.nlm.nih.gov/pubmed/23799921
http://dx.doi.org/10.1186/2045-9912-3-13

Ejemplares similares